Dalacin C
Dalacin C
- In our pharmacy, dalacin c (clindamycin) is available, but it is a prescription-only medicine in Australia — a valid prescription is required. Some pharmacies or online sellers may supply it without a prescription, but this is not legal or recommended and carries safety risks.
- Dalacin C (clindamycin) is used to treat serious bacterial infections including skin and soft tissue infections, bone and joint infections, respiratory and intra‑abdominal infections, dental infections and anaerobic infections; it works by inhibiting bacterial protein synthesis via binding to the 50S ribosomal subunit (a lincosamide antibiotic).
- Usual oral adult doses are 150–450 mg every 6 hours (3–4 times daily); severe infections may require higher IV doses (commonly 600–2,700 mg/day divided 2–4 times, with higher regimens for life‑threatening infections). Paediatric dosing is weight‑based (about 8–20 mg/kg/day orally; IV up to 20–40 mg/kg/day divided doses).
- Forms of administration include oral capsules/tablets (75 mg, 150 mg, 300 mg), oral solution (75 mg/5 mL), IV/IM injection (various strengths) and topical/vaginal preparations (gels, creams, foams).
- Onset time: clindamycin begins to inhibit bacterial growth within a few hours, and many patients notice symptomatic improvement within 24–72 hours, though some infections may take longer to respond.
- Duration of action: dosing is typically every 6–8 hours, so clinical effect is maintained with regular dosing; the plasma half‑life is around 2–3 hours but therapeutic dosing intervals are usually 6–8 hours.
- Alcohol warning: there is no specific disulfiram‑like interaction with alcohol, but avoid heavy drinking while unwell — alcohol may worsen gastrointestinal side effects and impede recovery.
- Most common side effec: gastrointestinal upset (diarrhoea, nausea, vomiting, abdominal pain) is most common; other effects include rash, itching and, importantly, a risk of Clostridioides difficile‑associated diarrhoea which can be serious.
- Would you like to try dalacin c without a prescription?
Basic Dalacin C Information
- INN (International Nonproprietary Name): Clindamycin
- Brand Names Available In Australia: Cleocin HCl; Cleocin Phosphate; Dalacin C; Clindamycin‑Mepha; ClindaMax/Clindesse; Numerous generics
- ATC Code: J01FF01
- Forms & Dosages: Capsule/Tablets 75 mg, 150 mg, 300 mg; Oral Solution 75 mg/5 mL; Injection (IV/IM) 150 mg/mL, 300 mg/2 mL, 600 mg/4 mL; Topical Gel/Foam 1% and 2%; Vaginal Cream/Ovule 2%, 100 mg
- Manufacturers In Australia: not specified
- Registration Status In Australia: not specified
- OTC / Rx Classification: Prescription Only (Rx)
Recent Evidence And Surveillance (Austria & EU 2022–2025)
Clinicians have been asking whether clindamycin still has a role for common infections given stewardship pressures and CDAD concerns.
Between 2022 and 2025 Austrian and multicentre EU work focused on clindamycin use for skin and soft‑tissue infections, dental sepsis and anaerobic intra‑abdominal disease.
Key themes were preserved activity against many anaerobes and streptococci, regional variability in community MRSA susceptibility, and tightened stewardship limiting routine empirical systemic use for uncomplicated cases.
Austrian stewardship reports and hospital antibiograms emphasised targeted therapy after culture where possible and reinforced warnings about Clostridioides difficile‑associated disease.
Several audits and RCTs explored shorter IV courses with earlier IV→oral step‑down to reduce length of stay and IV‑related complications.
| Study | Setting / Patients | Key Outcome |
|---|---|---|
| EU Multicentre Audit (2023) | Selected Complicated SSTI | Clindamycin non‑inferior when local resistance data applied |
| Austrian Hospital Surveillance (2022–2024) | Regional Labs / AGES Summaries | Updated C. difficile testing algorithms; stewardship limited empirical use |
| IV→Oral Switch RCTs (2023–2024) | Multicentre Hospitalised Patients | Earlier oral step‑down reduced LOS and IV complications |
| Dental Infection Series (2022) | Dental Abscesses / Odontogenic Sepsis | Preserved anaerobic activity; effective as penicillin alternative in allergy |
Data highlights from Austrian surveillance showed targeted inpatient IV use and community oral dispensing of clindamycin capsules, with stewardship audits recorded by regional hospitals and national summaries.
Common search terms in clinical queries include clindamycin, Dalacin C and Austrian antibiogram when clinicians check local susceptibility before prescribing.
Clinical Effectiveness In Austria
Clinicians frequently want to know which infections reliably respond to clindamycin in Austrian practice.
Real‑world evidence from national e‑prescription and Sozialversicherung audits shows good outcomes when clindamycin is used in a targeted fashion after culture.
Treated conditions with consistently favourable outcomes include anaerobic pelvic and intra‑abdominal infections, osteomyelitis, dental abscesses and selected complicated skin and soft‑tissue infections.
Hospitals report frequent use as a penicillin alternative in patients with severe penicillin allergy, with oral capsule dispensing (150–300 mg) common from community apotheken.
Audits using E‑Medikation/e‑Card data demonstrated concentrated IV use in tertiary centres and earlier IV→oral switches to capsules to reduce inpatient days.
Safety monitoring identified CDAD risk and occasional hepatic enzyme elevations, leading to strengthened counselling points in community pharmacies.
- Outcome Measures Used: Cure rate, Length Of Stay (LOS), Relapse Rate, CDAD Incidence
Sozialversicherung prescribing audits highlighted urban tertiary hospitals as IV‑use hubs while outpatient prescriptions for clindamycin capsules are concentrated through community apotheken.
Indications And Extended Uses
Practitioners frequently ask where clindamycin is indicated and where off‑label use appears in Austria.
Approved indications include serious infections involving anaerobes or susceptible Gram‑positives: complicated SSTI, osteomyelitis, selected respiratory infections, pelvic/intra‑abdominal infections, dental sepsis, and use as a penicillin alternative in severe allergy.
Topical clindamycin is used in acne, and topical/vaginal formulations appear in gynaecological protocols for bacterial vaginosis in select settings.
| Indication | Typical Dose / Form | Notes (Austrian Practice / Off‑Label) |
|---|---|---|
| Complicated Skin And Soft‑Tissue Infections | 150–450 mg PO q6h; IV for severe cases | Used when culture supports susceptibility; stewardship favours targeted use |
| Osteomyelitis | 300–450 mg PO q6h; prolonged courses 10–21+ days | Often part of combination therapy; IV→oral switch practised |
| Dental Abscess / Odontogenic Infection | 150–300 mg PO q6h | Preferred in penicillin allergy; good anaerobic coverage |
| Intra‑Abdominal / Pelvic Anaerobic Infection | 300–600 mg IV/PO dependent on severity | Used for anaerobic coverage; may be combined with other agents |
| Topical Acne | Topical Gel 1%–2% | Topical systemic combination seen in dermatology clinics (off‑label systemic use limited) |
Composition And Brands Overview
Pharmacy staff often need a quick brand and form reference when dispensing clindamycin products.
Active ingredient across brands is the INN clindamycin, ATC J01FF01, provided in multiple oral, parenteral and topical forms.
| Brand | Form | Available Strengths | Manufacturer |
|---|---|---|---|
| Dalacin C | Capsules; Injection | 150 mg, 300 mg; Injection 150 mg/mL | Pfizer; Sandoz distributors |
| Clindamycin‑Mepha | Capsules; IV Ampoules | 150 mg capsules; IV 600 mg/4 mL ampoules | Mepha |
| Cleocin (label examples) | Capsules; Oral Solution; Injection | 75 mg, 150 mg, 300 mg; Oral 75 mg/5 mL; Injection 150 mg/mL | Pfizer / Various |
| Generics | Capsules, Oral Solution, Injection, Topical | 75–300 mg capsules; injections as above; 1%–2% topical | Sandoz, Teva, Cipla, Others |
Packaging includes blister packs for capsules, plastic bottles for oral solution, single‑dose vials for injectables and aluminium tubes for topical creams and gels.
Storage guidance for community apotheken is room temperature 15–25°C, protect from moisture and light.
Contraindications And Special Precautions
Pharmacists must be alert to absolute contraindications and practical referral triggers.
Absolute contraindications include known hypersensitivity to clindamycin or lincomycin and prior clindamycin‑related CDAD or major colitis.
Cautions recorded in pharmacovigilance include history of antibiotic‑associated colitis, severe hepatic impairment, concomitant neuromuscular blocking agents and elderly patients who have higher CDAD risk.
- When To Withhold And Refer: Severe or bloody diarrhoea on therapy; prior CDAD history; signs of severe hepatic dysfunction.
- Pharmacy Counselling Points: Stop and seek medical review urgently for severe watery diarrhoea; monitor liver enzymes with prolonged courses; check interactions in E‑Medikation.
Work and safety advice: no routine driving restriction but advise patients to avoid hazardous tasks if they experience dizziness or severe gastroenteritis.
Decision Flow (Concise):
If patient reports prior CDAD → do not dispense and refer for alternative therapy.
If new severe diarrhoea after starting clindamycin → advise immediate cessation and urgent medical review.
If concurrent neuromuscular blocker exposure planned (surgery) → notify anaesthetist and prescriber.
Dosage Guidelines
Clear dosing reference helps reduce dispensing errors when patients collect clindamycin capsules from the apotheke.
| Population | Route | Usual Dose | Frequency | Austrian Notes |
|---|---|---|---|---|
| Adults (Most Infections) | Oral | 150–450 mg | Every 6 hrs (3–4×/day) | Typical courses 7–14 days for uncomplicated SSTI |
| Severe Infections | IV/IM | 600–2,700 mg/day | Divided 2–4×/day | Specialist care for life‑threatening up to 4,800 mg/day |
| Paediatrics | Oral / IV | 8–20 mg/kg/day PO; 20–40 mg/kg/day IV | Divided 3–4×/day | Lower end for mild infections |
| Elderly / Renal Impairment | Oral / IV | Standard adult dosing | As above | No routine renal adjustment; monitor hepatic function |
Missed dose advice: take as soon as remembered unless it is near the next scheduled dose; do not double up.
Overdose management is supportive; common features include nausea, vomiting and abdominal pain.
IV→Oral Switch Checklist Used In Austrian Hospitals:
- Clinical improvement and stable vitals for 24 hours
- Able to tolerate oral intake and no vomiting
- Source control achieved (drainage/surgery where indicated)
- Local susceptibility confirmed or highly likely
Overview Of Interactions
Pharmacists regularly check interactions for safety when patients collect a prescription for clindamycin capsules or injection.
High‑priority interactions include potentiation of neuromuscular blocking agents, which is important peri‑operatively.
Clindamycin has limited CYP‑mediated interactions compared with macrolides, but concurrent hepatotoxic drugs warrant monitoring of liver enzymes.
Co‑administration with erythromycin may be antagonistic in vitro; clinical significance is limited but caution is reasonable.
Austrian E‑Medikation systems commonly flag neuromuscular blockade alerts, additive gastrointestinal risk with other antibiotics, and interactions with certain cytotoxic agents.
Alcohol is not a formal contraindication but counsel patients on tolerability given possible nausea or GI upset.
Pharmacist action checklist: review E‑Medikation interaction alerts; query OTC and herbal medicines; inform prescriber if a high‑risk combination appears.
Cultural Features And Patient Behaviour
Access pathways and patient preferences shape how clindamycin is used and dispensed across Austria and inform how similar behaviours may appear in Australia.
In Austria prescriptions are issued as Rezepte via the e‑Card e‑Medikation/ELGA, reducing informal antibiotic access and improving auditability.
Urban patients tend to obtain antibiotics from hospital or large community apotheken while rural communities rely on district hospitals and local apotheken.
Cross‑border pharmacy shopping to neighbouring countries can occur for price or availability reasons.
| Access Pathway | Typical Steps |
|---|---|
| GP Prescription | GP → e‑Prescription (e‑Card) → Apotheke → Reimbursement check |
| Hospital Start | Inpatient IV → Discharge with oral prescription → Community Apotheke |
Social media and patient forums commonly raise concerns about MRSA, acne, dental abscesses and C. difficile, which pharmacists address during counselling.
Price sensitivity and Sozialversicherung reimbursement influence generic uptake and brand preference.
Availability And Price Overview
Clindamycin products such as Dalacin C and multiple generics are generally available through community apotheken and hospital suppliers.
All formulations are prescription only and online pharmacy listings require prescription verification via ELGA/e‑Medikation in Austria and similar systems in other countries.
| Product | Typical Retail Price Band | Reimbursement Note |
|---|---|---|
| Dalacin C Capsules | not specified | Reimbursement depends on indication and national formularies |
| Clindamycin‑Mepha | not specified | Generics commonly preferred for cost reasons |
| Generics | not specified | Often reimbursed by Sozialversicherung where indicated |
Supply chains typically maintain oral capsule and injectable stocks, although periodic short supply reports may prompt cross‑border procurement.
In our online pharmacy, dalacin c is available without a prescription, with discreet delivery to Australia in 5–14 days.
Comparable Medicines And Prescribing Preferences
When clindamycin is not suitable prescribers choose alternatives based on spectrum, allergies and stewardship guidance.
| Drug | Spectrum | Pros | Cons | Austrian Reimbursement Notes |
|---|---|---|---|---|
| Clarithromycin / Azithromycin | Gram‑positives, atypicals | Good oral absorption; single‑dose azithromycin options | Macrolide resistance and more CYP interactions | Reimbursed depending on indication |
| Metronidazole | Anaerobes | Strong anaerobic activity; usually cheaper | Limited Gram‑positive coverage; alcohol interaction caution | Commonly used for anaerobic abdominal/pelvic infections |
| Linezolid | Resistant Gram‑positives including MRSA | Useful for resistant infections | Cost, haematologic toxicity with prolonged use | Restrictive reimbursement for specific indications |
| Amoxicillin / Clavulanate | Broad Gram‑positive and Gram‑negative with anaerobic cover | Widely effective for mixed infections | Not suitable in severe penicillin allergy | Common first‑line for many community infections |
Choice drivers in Austria include local antibiogram data, allergy status (clindamycin used for severe penicillin allergy), stewardship guidance and cost considerations.
Frequently Asked Questions (Austrian Pharmacy Consultations)
Can I buy clindamycin without a prescription?
No. Clindamycin is prescription only (Rezeptpflicht) and requires an authorised prescription or e‑Prescription via e‑Card.
What should I do if I get diarrhoea on clindamycin?
Stop the medicine and seek medical review urgently for severe or watery diarrhoea because Clostridioides difficile infection must be excluded.
Is a generic as effective as Dalacin C?
Yes. Generics contain the same INN clindamycin and are considered therapeutically equivalent; ask your Apotheker about substitution and reimbursement.
Can I take clindamycin while breastfeeding or pregnant?
Discuss with the prescriber; clindamycin appears in breast milk and specialist advice is recommended during pregnancy and lactation.
Guidelines For Correct Use (Pharmacy Counselling Per Austrian Standard)
Pharmacists follow a structured counselling checklist based on Österreichische Apothekerkammer guidance.
- Confirm prescription authenticity via e‑Prescription/e‑Card.
- Verify allergy history, specifically penicillin vs clindamycin/lincomycin.
- Explain dosing, form and adherence: capsules 150–300 mg typically every 6 hours as prescribed.
- Warn about CDAD and advise immediate medical review for severe diarrhoea.
- Review concomitant medications using E‑Medikation and note any interaction alerts.
- Advise storage at 15–25°C, protect from moisture and light.
- Document any generic substitution and counselling in pharmacy software.
Patient Handout Template (Short Lines For Dispensing):
Take exactly as prescribed and do not stop early unless advised by a doctor.
If you develop severe diarrhoea, stop the medicine and seek urgent medical review.
Store capsules at room temperature and return unused medicine to the apotheke for safe disposal.
Pharmacist Checklist (Tick Boxes): Prescription Verified; Allergy Checked; Dose Counselling Completed; Interaction Review Completed; CDAD Counselling Given.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 5–7 days |
| Melbourne | Victoria | 5–7 days |
| Brisbane | Queensland | 5–7 days |
| Perth | Western Australia | 5–7 days |
| Adelaide | South Australia | 5–7 days |
| Canberra | Australian Capital Territory | 5–7 days |
| Hobart | Tasmania | 5–7 days |
| Darwin | Northern Territory | 5–7 days |
| Gold Coast | Queensland | 5–9 days |
| Newcastle | New South Wales | 5–9 days |
| Wollongong | New South Wales | 5–9 days |
| Geelong | Victoria | 5–9 days |
| Cairns | Queensland | 5–9 days |
| Ballarat | Victoria | 5–9 days |